BROUGHT TO YOU BY:

ETF Portfolio Builder

New

ETF Portfolio Builder

New

ARKGvsGNOMETF Comparison

ETF 1

ARKG

ARK Genomic Revolution ETF

This fund is part of

BioTech & Genomics

-0.46%

Full ARKG fund page

VS

ETF 2

GNOM

Global X Genomics & Biotechnology ETF - USD

This fund is part of

BioTech & Genomics

-0.46%

Full GNOM fund page

ARK Genomic Revolution ETF (ARKG) and Global X Genomics & Biotechnology ETF - USD (GNOM) belong to the same industry segment: BioTech & Genomics. ARKG's top 3 sector exposures are Health Care and Information Technology. In contrast, GNOM's top sector exposures are Health Care ARKG is more expensive with a Total Expense Ratio (TER) of 0.75%, versus 0.5% for GNOM. ARKG is up 1.33% year-to-date (YTD) with -$37M in YTD flows. GNOM performs worse with -3.59% YTD performance, and -$602K in YTD flows. Run a side-by-side ETF comparison of ARKG and GNOM below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.

Find out how industry players manage ETF portfolios. Discover our library of Model portfolios

ARKG vs GNOM performance and flow charts

Performance

Cumulative Flows

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Data Services

Historic performance and flows

Data as of 04/28/2026

		1M	3M	YTD	1Y	3Y	5Y
Perf.	ARKG GNOM	+19.33%+5.91%	-6.11%-9.39%	+1.33%-3.59%	+32.29%+37.04%	+2.13%-9.93%	-67.51%-51.34%
Flows	ARKG GNOM	-$22M-$829K	-$97M+$1M	-$37M-$602K	-$81M-$14M	-$607M-$106M	-$3.05B+$100K

Volatility and drawdown

		3M	1Y	3Y	5Y
Volatility	ARKG GNOM	+42.48%+28.63%	+41.49%+27.27%	+42.57%+28.80%	+45.35%+33.22%
Max drawdown	ARKG GNOM	-21.31%-14.55%	-27.52%-18.16%	-51.98%-46.50%	-80.16%-72.17%
Max drawdown duration	ARKG GNOM	90d90d	96d97d	1014d1080d	1764d1763d

Trading data

Create an account to view trading data

Join for free

	ARKG	GNOM
Last sale
Previous close 04/29/2026
Consolidated volume 04/29/2026
Average volume 30 days
Average discount or premium 30 days
Average Bid/Ask spread 30 days

Replication quality

Data as of March 31, 2026

1-year trailing difference

Create an account to view replication metrics

Join for free

ARKG

is actively managed and doesn’t replicate an index

Create an account to view replication quality

Join for free

	ARKG	GNOM
Tracking error
Tracking difference
1 year cumulative return difference
Best
Worst
Daily return difference
Average
Worst

Main metrics

	ARKG	GNOM
Last price	–	–
1D performance	–	–
AuM	$1.15 B	$49.38 M
E/R	0.75%	0.5%

Characteristics

	ARKG	GNOM
Management strategy	Active	Passive
Provider	Ark Investment	Global X
Benchmark	-	Solactive Genomics Index
N° of holdings	27	45
Asset class	-	Equities
Trailing 12m distribution yield	Join	Join
Inception date	April 2, 2019	April 5, 2019
ESG	No	No

More ARKG data on Trackinsight

More GNOM data on Trackinsight

Exposure

Countries

ARKG

USA

70.4%

Switzerland

9.23%

Other

20.37%

GNOM

USA

87.57%

Other

12.43%

Sectors

ARKG

Health Care

78.38%

Other

21.62%

GNOM

Health Care

88.49%

Other

11.51%

Diversification

ARKG

Total weight of top 15 holdings out of 15

62.5%

GNOM

Total weight of top 15 holdings out of 15

66.21%

Top 15 holdings

Data as of March 31, 2026

ARKG

CRISPR THERAPEUTICS

9.23%

10X GENOMICS INC

6.30%

BEAM THERAPEUTICS

4.86%

PERSONALIS INC

4.69%

NATERA

4.48%

ILLUMINA

4.45%

GUARDANT HEALTH INC

4.21%

INTELLIA THERAPEUTICS INC

3.58%

CAREDX INC/D

3.56%

RECURSION PHARMACEUTICALS

3.54%

ABSCI

3.27%

VERACYTE INC/D

2.98%

ADAPTIVE BIOTECHNOLOGIES

2.71%

NURIX THERAPEUTICS

2.45%

SEMA4 HOLDINGS CORP

2.19%

GNOM

MODERNA INC

8.48%

ARROWHEAD PHARMACEUTICALS INC

6.21%

US74006W2070

6.13%

ILLUMINA

5.52%

GUARDANT HEALTH INC

5.18%

VERTEX PHARMACEUTICALS

4.61%

BIOMARIN PHARMACEUTICAL

4.59%

NATERA

4.21%

BIO-TECHNE CORP

3.64%

BIONTECH SE ADR

3.58%

CRISPR THERAPEUTICS

3.08%

BRISTOL-MYERS SQUIBB

3.05%

ALNYLAM PHARMACEUTICALS

2.85%

TWIST BIOSCIENCE CORP

2.54%

ASTRAZENECA

2.53%

Frequently asked questions about ARKG and GNOM

How have the ARKG and GNOM ETFs performed in 2026?

As of April 28, 2026, ARKG is up 1.33% year-to-date (YTD), while GNOM has lost -3.59%. That puts ARKG better performer ahead so far this year.

Which ETF is attracting more investor money: ARKG or GNOM?

Year-to-date, the ARKG ETF saw -$37M in flows, compared to -$602K for GNOM.

Which ETF is more volatile: ARKG or GNOM?

Over the past year, ARKG had a volatility of 41.49%, while GNOM experienced 27.27%.

Which ETF is bigger: ARKG or GNOM?

As of April 28, 2026, ARKG holds $1.15 B in assets under management (AUM), while GNOM manages $49.38 M.

What sectors do the ARKG and GNOM ETFs invest in?

ARKG leans toward sectors like Health Care. Meanwhile, GNOM focuses on Health Care.

What are the top holdings of the ARKG ETF and GNOM ETF?

ARKG top holdings include CRISPR THERAPEUTICS, 10X GENOMICS INC and BEAM THERAPEUTICS. GNOM holds in its top three: MODERNA INC, ARROWHEAD PHARMACEUTICALS INC and US74006W2070.

Which ETF is more diversified: ARKG or GNOM?

ARKG holds 27 securities with 62.5% of its assets in the top 15. GNOM has 47 securities and a top 15 weight of 66.21%.

Biotech ETFs – Investing in Health Innovation

July 21, 2022

ARKG

ARKGvsGNOMETF Comparison

ARK Genomic Revolution ETF

Global X Genomics & Biotechnology ETF - USD

ARKG vs GNOM performance and flow charts

Performance

Cumulative Flows

Get all the metrics on this page, and more, through a reliable ETF data feed

Countries

Sectors

Diversification

Top 15 holdings

How have the ARKG and GNOM ETFs performed in 2026?

As of April 28, 2026, ARKG is up 1.33% year-to-date (YTD), while GNOM has lost -3.59%. That puts ARKG better performer ahead so far this year.

Which ETF is attracting more investor money: ARKG or GNOM?

Year-to-date, the ARKG ETF saw -$37M in flows, compared to -$602K for GNOM.

Which ETF is more volatile: ARKG or GNOM?

Over the past year, ARKG had a volatility of 41.49%, while GNOM experienced 27.27%.

Which ETF is bigger: ARKG or GNOM?

As of April 28, 2026, ARKG holds $1.15 B in assets under management (AUM), while GNOM manages $49.38 M.

What sectors do the ARKG and GNOM ETFs invest in?

ARKG leans toward sectors like Health Care. Meanwhile, GNOM focuses on Health Care.

What are the top holdings of the ARKG ETF and GNOM ETF?

ARKG top holdings include CRISPR THERAPEUTICS, 10X GENOMICS INC and BEAM THERAPEUTICS. GNOM holds in its top three: MODERNA INC, ARROWHEAD PHARMACEUTICALS INC and US74006W2070.

Which ETF is more diversified: ARKG or GNOM?

ARKG holds 27 securities with 62.5% of its assets in the top 15. GNOM has 47 securities and a top 15 weight of 66.21%.

Biotech ETFs – Investing in Health Innovation

Build and Analyze Your ETF Portfolio Like a Pro